Candida haemulonii Species Complex: A Mini-review.
Candida haemulonii complex; antifungal resistance; rare yeast pathogens; fungemia; emerging yeast pathogens
Journal
Mycopathologia
ISSN: 1573-0832
Titre abrégé: Mycopathologia
Pays: Netherlands
ID NLM: 7505689
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
01
02
2023
accepted:
12
05
2023
medline:
1
12
2023
pubmed:
1
7
2023
entrez:
30
6
2023
Statut:
ppublish
Résumé
Candida haemulonii species complex (CHSC) are emerging multidrug-resistant yeast pathogens able to cause life-threatening human infections in at-risk populations for invasive candidiasis worldwide. A recent laboratory survey conducted in 12 medical centers found that prevalence rates of Candida haemulonii complex isolates rose from 0.9 to 1.7% along the period between 2008 and 2019. We present a mini-review addressing recent aspects of the epidemiology, diagnosis and therapy of infections due to CHSC.
Identifiants
pubmed: 37391535
doi: 10.1007/s11046-023-00748-8
pii: 10.1007/s11046-023-00748-8
doi:
Substances chimiques
Antifungal Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
909-917Subventions
Organisme : Fundação de Amparo à Pesquisa do Estado de São Paulo
ID : 2019/24960-0
Organisme : Fundação de Amparo à Pesquisa do Estado de São Paulo
ID : 2017/02203-7
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Nature B.V.
Références
Colombo AL, Júnior JNA, Guinea J. Emerging multidrug-resistant Candida species. Curr Opin Infect Dis. 2017;30(6):528–38. https://doi.org/10.1097/QCO.0000000000000411 .
doi: 10.1097/QCO.0000000000000411
Poissy J, Damonti L, Bignon A, Khanna N, Von Kietzell M, Boggian K, Neofytos D, Vuotto F, Coiteux V, Artru F, Zimmerli S, Pagani JL, Calandra T, Sendid B, Poulain D, van Delden C, Lamoth F, Marchetti O, Bochud PY. FUNGINOS; Allfun French study groups. Risk factors for candidemia: a prospective matched case-control study. Crit Care. 2020;24(1):109. https://doi.org/10.1186/s13054-020-2766-1 .
doi: 10.1186/s13054-020-2766-1
Lima SL, Francisco EC, de Almeida Júnior JN, Santos DWCL, Carlesse F, Queiroz-Telles F, Melo ASA, Colombo AL. Increasing prevalence of multidrug-resistant Candida haemulonii species complex among all yeast cultures collected by a reference laboratory over the past 11 years. J Fungi Basel. 2020;6(3):110. https://doi.org/10.3390/jof6030110 .
doi: 10.3390/jof6030110
Yarrow D, Meyer SA. Proposal for amendment of the diagnosis of the genus Candida Berkhout nom. cons. Int J Syst Bacteriol. 1978;28:611–5.
doi: 10.1099/00207713-28-4-611
Van Uden Kolipinski MC. Torulopsis haemulonii nov. spec., a yeast from the Atlantic Ocean. Antonie Leeuwenhoek. 1962;28:78–80.
doi: 10.1007/BF02538724
Lavarde V, Daniel F, Saez H, Arnold M, Faguer B. Peritonite mycosique a Torulopsis haemulonii. Bull Soc Fr Mycol Med. 1984;13:173–6.
Ben-Ami R, Berman J, Novikov A, Bash E, Shachor-Meyouhas Y, Zakin S, Maor Y, Tarabia J, Schechner V, Adler A, Finn T. Multidrug-resistant Candida haemulonii and C. auris, Tel Aviv, Isreal. Emerg Infect Dis. 2017;23(1):195–203. https://doi.org/10.3201/eid2302.161486 .
doi: 10.3201/eid2302.161486
Hou X, Xiao M, Chen SC, Wang H, Cheng JW, Chen XX, Xu ZP, Fan X, Kong F, Xu YC. Identification and antifungal susceptibility profiles of Candida haemulonii species complex clinical isolates from a multicenter study in China. J Clin Microbiol. 2016;54(11):2676–80. https://doi.org/10.1128/JCM.01492-16 .
doi: 10.1128/JCM.01492-16
Kumar A, Prakash A, Singh A, Kumar H, Hagen F, Meis JF, Chowdhary A. Candida haemulonii species complex: an emerging species in India and its genetic diversity assessed with multilocus sequence and amplified fragment-length polymorphism analyses. Emerg Microbes Infect. 2016;5(5):e49. https://doi.org/10.1038/emi.2016.49 .
doi: 10.1038/emi.2016.49
Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Ellis D, Tullio V, Rodloff A, Fu W, Ling TA. Global antifungal surveillance group. Results from the ARTEMIS DISK global antifungal surveillance study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J Clin Microbiol. 2010;48(4):1366–77. https://doi.org/10.1128/JCM.02117-09 .
doi: 10.1128/JCM.02117-09
Pérez-Lazo G, Morales-Moreno A, Soto-Febres F, Hidalgo JA, Neyra E, Bustamante B. Liver abscess caused by Candida haemulonii var. vulnera. First case report in Peru. Rev Iberoam Micol. 2021;38(3):138–40. https://doi.org/10.1016/j.riam.2020.12.001 .
doi: 10.1016/j.riam.2020.12.001
de Almeida JN, Jr Assy JG, Levin AS, Del Negro GM, Giudice MC, Tringoni MP, Thomaz DY, Motta AL, Abdala E, Pierroti LC, Strabelli T, Munhoz AL, Rossi F, Benard G. Candida haemulonii complex species, Brazil. Emerg Infect Dis. 2016;22:561–3. https://doi.org/10.3201/eid2203.151610 .
doi: 10.3201/eid2203.151610
Fang SY, Wei KC, Chen WC, Lee SJ, Yang KC, Wu CS, Sun PL. Sun PL Primary deep cutaneous candidiasis caused by Candida duobushaemulonii in a 68-year-old man: the first case report and literature review. Mycoses. 2016;59:818–21. https://doi.org/10.1111/myc.12540 .
doi: 10.1111/myc.12540
Chen XF, Zhang H, Jia XM, Cao J, Li L, Hu XL, Li N, Xiao YL, Xia F, Ye LY, Hu QF, Wu XL, Ning LP, Hsueh PR, Fan X, Yu SY, Huang JJ, Xie XL, Yang WH, Li YX, Zhang G, Zhang JJ, Duan SM, Kang W, Wang T, Li J, Xiao M, Hou X, Xu YC. Antifungal susceptibility profiles and drug resistance mechanisms of clinical Candida duobushaemulonii isolates from China. Front Microbiol. 2022;5(13):1001845. https://doi.org/10.3389/fmicb.2022.1001845 .
doi: 10.3389/fmicb.2022.1001845
Boatto HF, Cavalcanti SD, Del Negro GM, Girão MJ, Francisco EC, Ishida K, Gompertz OF. Candida duobushaemulonii: an emerging rare pathogenic yeast isolated from recurrent vulvovaginal candidiasis in Brazil. Mem Inst Oswaldo Cruz. 2016;111(6):407–10. https://doi.org/10.1590/0074-02760160166 .
doi: 10.1590/0074-02760160166
Lehmann PF, Wu LC, Pruitt WR, Meyer SA, Ahearn DG. Unrelatedness of groups of yeasts within the Candida haemulonii complex. J Clin Microbiol. 1993;31(7):1683–7. https://doi.org/10.1128/jcm.31.7.1683-1687.1993 .
doi: 10.1128/jcm.31.7.1683-1687.1993
Cendejas-Bueno E, Kolecka A, Alastruey-Izquierdo A, Theelen B, Groenewald M, Kostrzewa M, Cuenca-Estrella M, Gómez-López A, Boekhout T. Reclassification of the Candida haemulonii complex as Candida haemulonii (C. haemulonii group I), C. duobushaemulonii sp nov (C. haemulonii group II), and C. haemulonii var. vulnera var. nov.: three multiresistant human pathogenic yeasts. J Clin Microbiol. 2012;50(11):3641–51. https://doi.org/10.1128/JCM.02248-12 .
doi: 10.1128/JCM.02248-12
Sipiczki M, Tap RM. Candida vulturna pro tempore sp. nov., a dimorphic yeast species related to the Candida haemulonis species complex isolated from flowers and clinical sample. Int J Syst Evol Microbiol. 2016;66(10):4009–15. https://doi.org/10.1099/ijsem.0.001302 .
doi: 10.1099/ijsem.0.001302
Sugita T, Takashima M, Poonwan N, Mekha N. Candida pseudohaemulonii sp. nov., an amphotericin B-and azole-resistant yeast species, isolated from the blood of a patient from Thailand. Microbiol Immunol. 2006;50(6):469–73. https://doi.org/10.1111/j.1348-0421.2006.tb03816.x .
doi: 10.1111/j.1348-0421.2006.tb03816.x
Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2009;53(1):41–4. https://doi.org/10.1111/j.1348-0421.2008.00083.x .
doi: 10.1111/j.1348-0421.2008.00083.x
de Jong AW, Al-Obaid K, Tap RM, van den Ende BG, Groenewald M, Joseph L, Ahmad S, Hagen F. Candida khanbhai sp. nov., a new clinically relevant yeast within the Candida haemulonii species complex. Med Mycol. 2023;61(2):009. https://doi.org/10.1093/mmy/myad009 .
doi: 10.1093/mmy/myad009
Xiao M, Chen SC, Kong F, Xu XL, Yan L, Kong HS, Fan X, Hou X, Cheng JW, Zhou ML, Li Y, Yu SY, Huang JJ, Zhang G, Yang Y, Zhang JJ, Duan SM, Kang W, Wang H, Xu YC. Distribution and antifungal susceptibility of Candida species causing Candidemia in China: an update from the CHIF-NET study. J Infect Dis. 2020;221(Suppl 2):S139–47. https://doi.org/10.1093/infdis/jiz573 .
doi: 10.1093/infdis/jiz573
Ramos R, Caceres DH, Perez M, Garcia N, Castillo W, Santiago E, Borace J, Lockhart SR, Berkow EL, Hayer L, Espinosa-Bode A, Moreno J, Jackson BR, Moran J, Chiller T, de Villarreal G, Sosa N, Vallabhaneni S, Red Nacional de Vigilancia Epidemiologica en Microbiologia Clinica. ; Emerging multidrug-resistant Candida duobushaemulonii infections in Panama hospitals: importance of laboratory surveillance and accurate identification. J Clin Microbiol. 2018;56(7):e00371-18. https://doi.org/10.1128/JCM.00371-18 .
doi: 10.1128/JCM.00371-18
Khan ZU, Al-Sweih NA, Ahmad S, Al-Kazemi N, Khan S, Joseph L, Chandy R. Outbreak of fungemia among neonates caused by Candida haemulonii resistant to amphotericin B, itraconazole, and fluconazole. J Clin Microbiol. 2007;45:2025–7. https://doi.org/10.1128/JCM.00222-07 .
doi: 10.1128/JCM.00222-07
Chen X, Jia X, Bing J, Zhang H, Hong N, Liu Y, Xi H, Wang W, Liu Z, Zhang Q, Li L, Kang M, Xiao Y, Yang B, Lin Y, Xu H, Fan X, Huang J, Gong J, Xu J, Xie X, Yang W, Zhang G, Zhang J, Kang W, Wang H, Hou X, Xiao M, Xu Y. Clonal dissemination of antifungal-resistant Candida haemulonii. China Emerg Infect Dis. 2023;29(3):576–84. https://doi.org/10.3201/eid2903.221082 .
doi: 10.3201/eid2903.221082
Ramos LS, Figueiredo-Carvalho MH, Barbedo LS, Ziccardi M, Chaves AL, Zancopé-Oliveira RM, Pinto MR, Sgarbi DB, Dornelas-Ribeiro M, Branquinha MH, Santos AL. Candida haemulonii complex: species identification and antifungal susceptibility profiles of clinical isolates from Brazil. J Antimicrob Chemother. 2015;70:111–5. https://doi.org/10.1093/jac/dku321 .
doi: 10.1093/jac/dku321
Coles M, Cox K, Chao A. Candida haemulonii: an emerging opportunistic pathogen in the United States? IDCases. 2020;21:e00900. https://doi.org/10.1016/j.idcr.2020.e00900 .
doi: 10.1016/j.idcr.2020.e00900
Yuvaraj A, Rohit A, Koshy PJ, Nagarajan P, Nair S, Abraham G. Rare occurrence of fatal Candida haemulonii peritonitis in a diabetic CAPD patient. Ren Fail. 2014;36(9):1466–7. https://doi.org/10.3109/0886022X.2014.944067 .
doi: 10.3109/0886022X.2014.944067
Awada B, Alam W, Chalfoun M, Araj G, Bizri AR. COVID-19 and Candida duobushaemulonii superinfection: a case report. J Mycol Med. 2021;31(3):101168. https://doi.org/10.1016/j.mycmed.2021.101168 .
doi: 10.1016/j.mycmed.2021.101168
Candida haemulonii (van Uden & Kolipinski) S.A. Meyer & Yarrow (Yarrow and Meyer 1978). In: The Yeasts, a Taxonomic Study, 5th ed., Vol. 3. Kurtzman CP, Fell JW, Boekhout T, eds. Elsevier, Amsterdam, pp. 1103–1104
Zurita J, Paz Y, Miño A, Solís MB, Sevillano G. Failed identification of Candida vulturna using the updated Vitek 2 yeast identification system, version 9.02 and CHROMagar Candida Plus. New Microbes New Infect. 2022;48:101012. https://doi.org/10.1016/j.nmni.2022.101012 .
doi: 10.1016/j.nmni.2022.101012
Muthusamy A, Rao M, Chakrabarti A, Velayuthan RD. Case report: catheter related blood stream infection caused by Candida vulturna. Med Mycol Case Rep. 2022;16(36):27–30. https://doi.org/10.1016/j.mmcr.2022.04.001 .
doi: 10.1016/j.mmcr.2022.04.001
Sasoni N, Maidana M, Latorre-Rapela MG, Morales-Lopez S, Berrio I, Gamarra S, Garcia-Effron G. Candida auris and some Candida parapsilosis strains exhibit similar characteristics on CHROMagarTM Candida plus. Med Mycol. 2022;60(10):062. https://doi.org/10.1093/mmy/myac062 .
doi: 10.1093/mmy/myac062
Marathe A, Zhu Y, Chaturvedi V, Chaturvedi S. Utility of CHROMagar™ Candida Plus for presumptive identification of Candida auris from surveillance samples. Mycopathologia. 2022;187(5–6):527–34. https://doi.org/10.1007/s11046-022-00656-3 .
doi: 10.1007/s11046-022-00656-3
Tamura T, Alshahni MM, Makimura K. Evaluation of CHROMagar™ Candida plus chromogenic agar for the presumptive identification of Candida auris. Microbiol Immunol. 2022;66(6):292–8. https://doi.org/10.1111/1348-0421.12973 .
doi: 10.1111/1348-0421.12973
de Jong AW, Dieleman C, Carbia M, Mohd Tap R, Hagen F. Performance of two novel chromogenic media for the identification of multidrug-resistant Candida auris compared with other commercially available formulations. J Clin Microbiol. 2021;59(4):e03220-e3320.
Theill L, Dudiuk C, Morales-Lopez S, Berrio I, Rodríguez JY, Marin A, Gamarra S, Garcia-Effron G. Single-tube classical PCR for Candida auris and Candida haemulonii identification. Rev Iberoam Micol. 2018;35(2):110–2. https://doi.org/10.1016/j.riam.2018.01.003 .
doi: 10.1016/j.riam.2018.01.003
Grenfell RC, da Silva Junior AR, Del Negro GM, Munhoz RB, Gimenes VM, Assis DM, Rockstroh AC, Motta AL, Rossi F, Juliano L, Benard G, de Almeida Júnior JN. Identification of Candida haemulonii complex species: use of ClinProTools(TM) to overcome limitations of the Bruker Biotyper(TM), VITEK MS(TM) IVD, and VITEK MS(TM) RUO databases. Front Microbiol. 2016;16(7):940. https://doi.org/10.3389/fmicb.2016.00940 .
doi: 10.3389/fmicb.2016.00940
Oberoi JK, Wattal C, Goel N, Raveendran R, Datta S, Prasad K. Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India. Indian J Med Res. 2012;136:997–1003 (PMID: 23391796).
CLINICAL BREAKPOINTS CLSI (2022) Epidemiological cutoff values for antifungal susceptibility testing, 4th ed CLSI supplement M57S. Clinical and Laboratory Standards Institute, Wayne.
Gade L, Muñoz JF, Sheth M, Wagner D, Berkow EL, Forsberg K, Jackson BR, Ramos-Castro R, Escandón P, Dolande M, Ben-Ami R, Espinosa-Bode A, Caceres DH, Lockhart SR, Cuomo CA, Litvintseva AP. Understanding the emergence of multidrug-resistant Candida: using whole-genome sequencing to describe the population structure of Candida haemulonii species complex. Front Genet. 2020;10(11):554. https://doi.org/10.3389/fgene.2020.00554 .
doi: 10.3389/fgene.2020.00554
Silva CM, Carvalho-Parahym AM, Macêdo DP, Lima-Neto RG, Francisco EC, Melo AS, da Conceição M, Silva M, Jucá MB, Mello LR, Amorim RM, Neves RP. Neonatal candidemia caused by Candida haemulonii: case report and review of literature. Mycopathologia. 2015;180(1–2):69–73. https://doi.org/10.1007/s11046-015-9872-7 .
doi: 10.1007/s11046-015-9872-7
Chen XF, Hou X, Zhang H, Jia XM, Ning LP, Cao W, Fan X, Huang JJ, Yang WH, Zhang G, Zhang JJ, Kang W, Xiao M, Xu YC. First two fungemia cases caused by Candida haemulonii var. vulnera in China with emerged antifungal resistance. Front Microbiol. 2022;13:1036351. https://doi.org/10.3389/fmicb.2022.1036351 .
doi: 10.3389/fmicb.2022.1036351
Xia FQ, Ye CY, Xie WW, Poont ND, Zhou YH. Successful fluconazole treatment of catheter-related candidemia caused by Candida haemulonii: report of 2 neonatal cases. Arch Argent Pediatr. 2018;116(5):e663–6. https://doi.org/10.5546/aap.2018.eng.e663 .
doi: 10.5546/aap.2018.eng.e663
Kim S, Ko KS, Moon SY, Lee MS, Lee MY, Son JS. Catheter-related candidemia caused by Candida haemulonii in a patient in long-term hospital care. J Korean Med Sci. 2011;26(2):297–300. https://doi.org/10.3346/jkms.2011.26.2.297 .
doi: 10.3346/jkms.2011.26.2.297
Ramos LS, Oliveira SSC, Souto XM, Branquinha MH, Santos ALS. Planktonic growth and biofilm formation profiles in Candida haemulonii species complex. Med Mycol. 2017;55(7):785–9. https://doi.org/10.1093/mmy/myx005 .
doi: 10.1093/mmy/myx005
Ramos LS, Mello TP, Branquinha MH, Santos ALS. Biofilm formed by Candida haemulonii species complex: structural analysis and extracellular matrix composition. J Fungi Basel. 2020;6(2):46. https://doi.org/10.3390/jof6020046 .
doi: 10.3390/jof6020046
Lima SL, Rossato L, de Salles Azevedo Melo A. Evaluation of the potential virulence of Candida haemulonii species complex and Candida auris isolates in Caenorhabditis elegans as an in vivo model and correlation to their biofilm production capacity. Microb Pathog. 2020;148:104461. https://doi.org/10.1016/j.micpath.2020.104461 .
doi: 10.1016/j.micpath.2020.104461
Deng Y, Li S, Bing J, Liao W, Tao L. Phenotypic switching and filamentation in Candida haemulonii, an emerging opportunistic pathogen of humans. Microbiol Spectr. 2021;9(3):e0077921. https://doi.org/10.1128/Spectrum.00779-21 .
doi: 10.1128/Spectrum.00779-21
Ramos LS, Oliveira SSC, Braga-Silva LA, Branquinha MH, Santos ALS. Secreted aspartyl peptidases by the emerging, opportunistic and multidrug-resistant fungal pathogens comprising the Candida haemulonii complex. Fungal Biol. 2020;124(8):700–7. https://doi.org/10.1016/j.funbio.2020.04.001 .
doi: 10.1016/j.funbio.2020.04.001
Souto XM, Ramos LS, Branquinha MH, Santos ALS. Identification of cell-associated and secreted serine-type peptidases in multidrug-resistant emergent pathogens belonging to the Candida haemulonii complex. Folia Microbiol Praha. 2019;64(2):245–55. https://doi.org/10.1007/s12223-018-0651-y .
doi: 10.1007/s12223-018-0651-y
Ramos LS, Figueiredo-Carvalho MHG, Silva LN, Siqueira NLM, Lima JC, Oliveira SS, Almeida-Paes R, Zancopé-Oliveira RM, Azevedo FS, Ferreira ALP, Branquinha MH, Santos ALS. The threat called Candida haemulonii species complex in rio de Janeiro State, Brazil: focus on antifungal resistance and virulence attributes. J Fungi Basel. 2022;8(6):574. https://doi.org/10.3390/jof8060574 .
doi: 10.3390/jof8060574
Kathuria S, Singh PK, Sharma C, Prakash A, Masih A, Kumar A, Meis JF, Chowdhary A. Multidrug-resistant Candida auris misidentified as Candida haemulonii: Characterization by matrix-assisted laser desorption ionization-time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by Vitek 2, CLSI broth microdilution, and Etest method. J Clin Microbiol. 2015;53(6):1823–30. https://doi.org/10.1128/JCM.00367-15 .
doi: 10.1128/JCM.00367-15
Li MC, Tang HJ, Wu CJ, Wang SW, Su SL, Liu WL, Ko WC, Chen YC. Species identification and antifungal susceptibility of uncommon blood yeast isolates. J Microbiol Immunol Infect. 2022;55(1):130–7. https://doi.org/10.1016/j.jmii.2021.01.009 .
doi: 10.1016/j.jmii.2021.01.009
Shin JH, Kim MN, Jang SJ, Ju MY, Kim SH, Shin MG, Suh SP, Ryang DW. Detection of amphotericin B resistance in Candida haemulonii and closely related species by use of the Etest, Vitek-2 yeast susceptibility system, and CLSI and EUCAST broth microdilution methods. J Clin Microbiol. 2012;50(6):1852–5. https://doi.org/10.1128/JCM.06440-11 .
doi: 10.1128/JCM.06440-11
Rodrigues DKB, Bonfietti LX, Garcia RA, Araujo MR, Rodrigues JS, Gimenes VMF, Melhem MSC. Antifungal susceptibility profile of Candida clinical isolates from 22 hospitals of São Paulo state, Brazil. Braz J Med Biol Res. 2021;54(9):e10928. https://doi.org/10.1590/1414-431X2020e10928 .
doi: 10.1590/1414-431X2020e10928
Muro MD, Motta Fde A, Burger M, et al. Echinocandin resistance in two Candida haemulonii isolates from pediatric patients. J Clin Microbiol. 2012;50:3783–5. https://doi.org/10.1128/JCM.01136-12 .
doi: 10.1128/JCM.01136-12
Ruan SY, Kuo YW, Huang CT, Hsiue HC, Hsueh PR. Infections due to Candida haemulonii: species identification, antifungal susceptibility and outcomes. Int J Antimicrob Agents. 2010;35(1):85–8. https://doi.org/10.1016/j.ijantimicag.2009.08.009 .
doi: 10.1016/j.ijantimicag.2009.08.009
Frías-De-León MG, Martínez-Herrera E, Acosta-Altamirano G, Arenas R, Rodríguez-Cerdeira C. Superficial candidosis by Candida duobushaemulonii: an emerging microorganism. Infect Genet Evol. 2019;75:103960. https://doi.org/10.1016/j.meegid.2019.103960 .
doi: 10.1016/j.meegid.2019.103960
Aslani N, Shokohi T, Ataollahi MR, Ansari S, Gholampour Y, Khani Jeihooni A, Afsarian MH. In vitro activity of four triazole antifungal drugs against clinically common and uncommon yeast species. Curr Med Mycol. 2019;5(4):14–9. https://doi.org/10.18502/cmm.5.4.1949 .
doi: 10.18502/cmm.5.4.1949
Crouzet J, Sotto A, Picard E, Lachaud L, Bourgeois N. A case of Candida haemulonii osteitis: clinical features, biochemical characteristics, and antifungal resistance profile. Clin Microbiol Infect. 2011;17(7):1068–70. https://doi.org/10.1111/j.1469-0691.2011.03471.x .
doi: 10.1111/j.1469-0691.2011.03471.x
Almeida JN Jr, Motta AL, Rossi F, Abdala E, Pierrotti LC, Kono AS, Diz Mdel P, Benard G, Del Negro GM. First report of a clinical isolate of Candida haemulonii in Brazil. Clin Sao Paulo. 2012;67(10):1229–31. https://doi.org/10.6061/clinics/2012(10)18 .
doi: 10.6061/clinics/2012(10)18
Chen J, Hu N, Xu H, Liu Q, Yu X, Zhang Y, Huang Y, Tan J, Huang X, Zeng L. Molecular epidemiology, antifungal susceptibility, and virulence evaluation of candida isolates causing invasive infection in a tertiary care teaching hospital. Front Cell Infect Microbiol. 2021;15(11):721439. https://doi.org/10.3389/fcimb.2021.721439 .
doi: 10.3389/fcimb.2021.721439
Melhem MS, Bertoletti A, Lucca HR, Silva RB, Meneghin FA, Szeszs MW. Use of the VITEK 2 system to identify and test the antifungal susceptibility of clinically relevant yeast species. Braz J Microbiol. 2014;44(4):1257–66. https://doi.org/10.1590/S1517-83822014005000018 .
doi: 10.1590/S1517-83822014005000018
Desnos-Ollivier M, Lortholary O, Bretagne S, Dromer F. Azole susceptibility profiles of more than 9,000 clinical yeast isolates belonging to 40 common and rare species. Antimicrob Agents Chemother. 2021;65(6):e02615-e2620. https://doi.org/10.1128/AAC.02615-20 .
doi: 10.1128/AAC.02615-20